Index

Fetal & Neonatal Physiology — MRCOG Part 1 Deep-Dive Study Document

Exam Weighting: High. Fetal and neonatal physiology underpins understanding of fetal surveillance, intrapartum care, neonatal resuscitation, and management of high-risk pregnancies. Questions commonly appear on fetal circulation, shunts, placental transport, CTG interpretation, acid-base balance, neonatal jaundice, and thermoregulation.

Target Word Count: ~22,000 words | Last Updated: May 2026

Table of Contents

1. Fetal Growth & Development
2. Fetal Circulation
3. Placental Physiology
4. Fetal Endocrinology
5. Fetal Monitoring
6. Transition at Birth
7. Neonatal Physiology
8. Acid-Base Balance in Labour
9. Summary Tables & Revision Aids
10. Clinical Correlations Compendium
11. MRCOG Part 1 Exam-Style Questions

1. Fetal Growth & Development

1.1 Overview of Fetal Growth Phases

Fetal growth is not a linear process. It follows a sigmoid curve characterised by three distinct phases that reflect changing cellular dynamics:

Clinical Correlation: The phase of growth at which an insult occurs determines the pattern of fetal growth restriction. A first-trimester insult (e.g., chromosomal abnormality, TORCH infection) causes symmetrical IUGR (all parameters affected). A third-trimester insult (e.g., pre-eclampsia, placental insufficiency) causes asymmetrical IUGR (head sparing, abdominal circumference affected disproportionately).

1.2 Crown–Rump Length (CRL)

The CRL is the gold standard for pregnancy dating in the first trimester.

• Measured: 7–13+6 weeks gestation (ideally at 11–13+6 weeks as part of combined screening).
• Accuracy: ±3–5 days when measured in first trimester.
• Correlation with GA: CRL (mm) + 42 ≈ gestational age in days (simplified; multiple regression formulae exist — Robinson & Fleming, Hadlock).
• Growth rate: ~1 mm per day in first trimester.
• Beyond 14 weeks: Biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC), and femur length (FL) are used for dating.

Formula Example (Hadlock): GA (weeks) = 8.052 × (CRL)[sup]0.5[/sup] + 23.73 (simplified for clinical use).

Important Caveat: In IVF pregnancies, CRL-based dating may need adjustment as embryos may be smaller in early first trimester.

1.3 Fetal Weight Estimation

Estimated fetal weight (EFW) is calculated using ultrasound biometric parameters. The most widely used formulae are those of Hadlock et al.

Hadlock Formulae (commonly used combinations):

• EFW = 10^(1.326 – 0.00326 × AC × FL + 0.01007 × HC + 0.0438 × AC + 0.158 × FL)
• Accuracy: ±15% in 95% of cases.
• Systematic error: EFW tends to overestimate weight in SGA fetuses and underestimate in LGA fetuses.

Clinical Use: - EFW <10th centile → SGA/IUGR workup - EFW >90th centile → LGA/macrosomia workup (GDM screening) - EFW plotted on customised growth charts improves detection of pathological growth restriction.

Abdominal circumference (AC) is the single best predictor of fetal weight — it reflects liver size and glycogen/ fat stores. A single AC measurement <5th centile has ~80% sensitivity for IUGR.

1.4 Intrauterine Growth Restriction (IUGR)

IUGR describes a fetus that fails to achieve its genetically determined growth potential. It is distinct from SGA (size <10th centile) — a fetus can be SGA but constitutionally small (constitutionally small baby), or AGA but growth-restricted.

1.4.1 Symmetrical (Type I) IUGR

1.4.2 Asymmetrical (Type II) IUGR

1.5 Growth Charts: Customised vs Population

Evidence: A multicentre UK study (Gardosi et al., 2018) showed customised charts reduce the stillbirth rate by ~30% compared with population charts. RCOG Green-top Guideline No. 31 supports the use of customised growth charts for SGA surveillance.

1.6 Doppler in FGR

Doppler ultrasound assesses blood flow velocity waveforms in fetal and maternal vessels. It provides real-time information about fetoplacental haemodynamics.

1.6.1 Uterine Artery Doppler

• Assesses: Trophoblastic invasion of spiral arteries.
• Normal: Low-resistance, high-velocity waveform with persistent forward flow throughout diastole (by 24 weeks).
• Abnormal: Persistence of high-resistance waveform with early diastolic notch (bilateral notches more significant).
• Use: First-trimester screening for pre-eclampsia and FGR (PI + maternal factors). In second trimester, abnormal UtA Doppler predicts ~40% of early-onset FGR.

1.6.2 Umbilical Artery (UA) Doppler

• Assesses: Resistance in the fetoplacental circulation.
• Normal: High-velocity forward flow throughout cardiac cycle. PI decreases with advancing gestation (as placental vascular bed expands).
• Progression of abnormality:
• Raised PI >95th centile
• Absent end-diastolic flow (AEDF)
• Reversed end-diastolic flow (REDF) — ominous sign
• Clinical significance:
• AEDF → significantly increased risk of perinatal death, acidosis, NICU admission.
• REDF → extremely high perinatal mortality (up to 50% in some series); delivery usually indicated at 32–34 weeks if lung maturity established.
• UA Doppler reduces perinatal mortality by ~30% in high-risk pregnancies (GRIT study, TRUFFLE study).

1.6.3 Middle Cerebral Artery (MCA) Doppler

• Assesses: Fetal cerebrovascular response to hypoxia ("brain-sparing effect").
• Normal: High-resistance waveform in normoxic fetus.
• Hypoxia: Vasodilation of cerebral vessels → decreased PI (<5th centile).
• Peak systolic velocity (PSV):
• Used primarily for detection of fetal anaemia (e.g., parvovirus B19, red cell alloimmunisation).
• MCA-PSV >1.5 MoM → moderate-to-severe anaemia (predicts need for IUT).
• In FGR: low PI (vasodilation) combined with low PSV (reduced cardiac output) is ominous.

1.6.4 Ductus Venosus (DV) Doppler

• Assesses: Right heart function and severity of hypoxic insult.
• Normal: Forward flow throughout atrial contraction (a-wave positive).
• Abnormal:
• Reduced/nadir a-wave (a-wave low or absent)
• Reversed a-wave (atrial contraction causes flow reversal) — preterminal sign
• Clinical use in FGR staging: DV Doppler abnormalities are late findings and indicate severe fetal compromise. The TRUFFLE study showed that timing delivery based on DV changes (late changes) vs CTG changes improved neurodevelopmental outcomes at 2 years.

1.6.5 Cerebroplacental Ratio (CPR)

• Formula: CPR = MCA PI / UA PI
• Normal: CPR >5th centile (usually >1.08 at term, but centile-based interpretation essential).
• Abnormal: CPR <5th centile.
• Significance: Detects "brain sparing" earlier than either MCA or UA alone. Associated with adverse perinatal outcomes even in appropriately grown fetuses (late-onset FGR). Low CPR is associated with:
• Increased operative delivery for fetal distress
• Lower umbilical cord pH at birth
• Higher NICU admission rates
• Lower neurodevelopmental scores at 2 years

1.7 Amniotic Fluid Volume Regulation

1.7.1 Composition and Dynamics

Amniotic fluid volume (AFV) changes throughout gestation:

1.7.2 Regulation Pathways

AFV = (fetal urine output + lung fluid) – (fetal swallowing + intramembranous absorption)

1.7.3 Oligohydramnios

Definition: Amniotic fluid index (AFI) <5 cm OR single deepest vertical pocket (MVP) <2 cm.

Aetiologies: - Fetal: Renal agenesis (Potter syndrome), posterior urethral valves, polycystic kidneys, ureteral obstruction, severe IUGR (reduced renal perfusion) - Maternal: Medications (ACE inhibitors, NSAIDs, indomethacin), dehydration - Placental: Placental insufficiency, abruption, PPROM (most common cause) - Post-term: Physiologic decline in placental function

Consequences: - Pulmonary hypoplasia (Potter sequence) — critical if onset <24 weeks - Cord compression → variable decelerations - Skeletal deformities (clubfoot, hip dislocation) - Meconium aspiration syndrome (thick meconium in reduced fluid) - Increased risk of caesarean section

1.7.4 Polyhydramnios

Definition: AFI >24 cm OR MVP >8 cm.

Aetiologies: - Idiopathic (~50%) — often mild - Maternal: Diabetes mellitus (osmotic diuresis from fetal hyperglycaemia) - Fetal: - Impaired swallowing: oesophageal atresia, tracheo-oesophageal fistula, neuromuscular disorders, anencephaly - Increased urine output: diabetes insipidus (rare), twin-to-twin transfusion (recipient twin) - Congenital diaphragmatic hernia, skeletal dysplasias, cardiac abnormalities - Placental: Chorioangioma

Consequences: - Preterm labour (overdistension) - Malpresentation - Cord prolapse - Placental abruption (rapid decompression) - Postpartum haemorrhage (uterine atony)

1.7.5 AFV Measurement

NICE Guidance: Single deepest pocket is recommended for AFV assessment in multiple pregnancy. In singleton pregnancies, either AFI or MVP can be used.

2. Fetal Circulation

2.1 Overview: The Parallel Circulation

Fetal circulation is fundamentally different from postnatal circulation. In postnatal life, the circulation is in series (right heart → lungs → left heart → body). In fetal life, the circulation is in parallel because the lungs are non-functional for gas exchange. Three key shunts enable blood to bypass the pulmonary circulation:

1. Ductus venosus — shunts oxygenated umbilical venous blood past the liver into the IVC
2. Foramen ovale — shunts oxygenated blood from RA to LA, bypassing the RV and pulmonary circulation
3. Ductus arteriosus — shunts deoxygenated blood from pulmonary artery to descending aorta, bypassing the lungs

2.2 Detailed Pathway of Fetal Circulation

2.2.1 Oxygenated Blood

Placenta (gas exchange)
    ↓
Umbilical vein (O2 sat ~80%)
    ↓
**Ductus venosus** (bypasses liver sinusoids)
    ↓
Inferior vena cava (mixes with deoxygenated blood from lower body; O2 sat ~70%)
    ↓
Right atrium
    ↓
**Foramen ovale** → Left atrium
    ↓
Left ventricle
    ↓
Ascending aorta
    ↓
**Upper body and head** (heart, brain — receive most oxygenated blood)

Key concept: The fetal brain and heart receive the most highly oxygenated blood via this preferential streaming pathway.

2.2.2 Deoxygenated Blood

Superior vena cava (O2 sat ~40% — from upper body/brain)
    ↓
Right atrium → Right ventricle
    ↓
Pulmonary artery
    ↓
**Ductus arteriosus** (~90% of RV output bypasses lungs)
    ↓
Descending aorta (mixes with oxygenated blood from aortic arch)
    ↓
**Umbilical arteries** (O2 sat ~60%) → Placenta

Clinical Note: The fetal right ventricle supplies ~65% of combined cardiac output (CCO), reflecting the dominant role of the right heart in fetal circulation. The left ventricle supplies ~35%. Fetal CCO is ~450 mL/kg/min at term.

2.3 Oxygen Saturations in Fetal Circulation

The oxygen saturation (SaO₂) at key points in the fetal circulation reflects the streaming, mixing, and shunting patterns:

Key Point: The fetal brain receives blood with SaO₂ of ~65% (ascending aorta). This is lower than the 95–100% SaO₂ after birth, but adequate because: - Fetal Hb (HbF) has higher O₂ affinity - Fetal haemoglobin concentration is higher (~15–17 g/dL at term) - The left-shifted O₂ dissociation curve (see below) ensures O₂ loading at the relatively low pO₂ of the placenta

2.4 Fetal Haemoglobin (HbF)

2.4.1 Structure and Synthesis

• Structure: α₂γ₂ (two alpha chains, two gamma chains). In contrast, adult HbA is α₂β₂.
• Synthesis: Produced from ~6 weeks gestation in the yolk sac (primitive erythropoiesis), then in the liver (definitive erythropoiesis) from ~8–10 weeks, with splenic and bone marrow contributions later.
• HbF predominance: >90% of haemoglobin at birth; by 6 months of age HbF is <5%.
• γ-chain variants: HbF can have glycine (Gγ) or alanine (Aγ) at position 136. The Gγ:Aγ ratio changes from 3:1 at birth to 2:3 in adult HbF.

2.4.2 Oxygen Affinity and the HbF–HbA Comparison

2.4.3 The Oxygen Dissociation Curve and the Double Bohr Effect

The Bohr Effect: An increase in CO₂ or decrease in pH (increased [H⁺]) decreases haemoglobin's affinity for O₂ (right-shifts the dissociation curve). This facilitates O₂ unloading in tissues where pH is low and CO₂ is high.

The Double Bohr Effect is the elegant mechanism by which O₂ transfer from mother to fetus is maximised at the placenta:

1. At the placenta:
2. Maternal side: Maternal blood gives up O₂ → becomes more deoxygenated → Hb binds more H⁺ (Haldane effect) → pH rises → maternal curve shifts left → further O₂ release (even at low pO₂)

3. Fetal side: Fetal blood takes up O₂ → releases H⁺ (reverse Haldane effect) → pH falls slightly → fetal curve shifts right → facilitates O₂ unloading to fetal tissues later

4. The net result: At any given pO₂ gradient across the placenta, the double Bohr effect increases O₂ transfer by ~20–30%.

Simplified: The maternal curve shifts left at the placenta (aiding O₂ release), while the fetal curve shifts right at the placenta (aiding O₂ uptake). This is the double Bohr effect — the simultaneous, mutually beneficial shift of both curves.

2.5 Fetal Shunts: Detailed Anatomy, Physiology and Closure

2.5.1 Ductus Venosus

Why doesn't all blood pass through the liver? The DV allows the most highly oxygenated umbilical venous blood to bypass the liver, which is metabolically less active in fetal life and can use the less-oxygenated portal venous blood. This preferential streaming is critical for maintaining high O₂ delivery to the brain and heart.

2.5.2 Foramen Ovale

Clinical Correlation: In congenital heart disease with hypoplastic left heart syndrome, the FO is the only source of left heart filling. A restrictive FO (small opening) causes severe cyanosis and requires urgent balloon septostomy (Rashkind procedure) — typically performed in the first days of life.

2.5.3 Ductus Arteriosus

2.5.3.1 Factors Maintaining Ductus Arteriosus Patency In Utero

The ductus arteriosus must remain patent during fetal life. Several factors ensure this:

1. Low fetal pO₂ (~18–20 mmHg in the ductus) — The ductus is exquisitely sensitive to O₂. Low pO₂ maintains relaxation of smooth muscle.
2. Prostaglandins (especially PGE₂):
3. PGE₂ is the principal vasodilator maintaining ductal patency.
4. PGE₂ is produced by the ductal wall itself (via COX-1 and COX-2), the placenta, and fetal vessels.
5. PGE₂ acts on EP₂ and EP₄ receptors → ↑cAMP → smooth muscle relaxation.
6. PGE₂ levels are high in fetal circulation (placental production is significant).
7. Prostacyclin (PGI₂): Also contributes to vasodilation via ↑cAMP.
8. Nitric oxide (NO): Further vasodilation through ↑cGMP.
9. Low O₂ tension: Inhibits endothelin-1 (ET-1) production and promotes vasodilation.

2.5.3.2 Mechanism of Ductus Arteriosus Closure at Birth

2.5.3.3 Patent Ductus Arteriosus (PDA) — Why and How We Treat It

Why does PDA occur? - Prematurity: The most common cause. The preterm ductus is: - More sensitive to PGE₂ and NO - Less sensitive to O₂ (incomplete development of O₂-sensing Kv channels) - Less responsive to O₂-induced constriction - Patency is directly related to degree of prematurity: >80% in <1000g infants - Prolonged hypoxia (e.g., respiratory distress syndrome, pulmonary hypertension) - Congenital rubella syndrome (inhibits ductal smooth muscle development) - Genetic factors (some familial PDA syndromes)

Why treat PDA? A haemodynamically significant PDA causes: - Left-to-right shunt (aorta → pulmonary artery) → pulmonary overcirculation → pulmonary oedema - Diastolic steal from systemic circulation → impaired end-organ perfusion (necrotising enterocolitis, renal impairment) - Increased ventilator dependence - Intraventricular haemorrhage (due to fluctuating cerebral blood flow) - Congestive heart failure (in severe, persistent cases)

Treatment: - Indomethacin/Ibuprofen (COX inhibitors): - Mechanism: Inhibit COX-1 and COX-2 → ↓ PGE₂ synthesis → promotes ductal constriction - Both cross the ductus wall and reduce PGE₂ production locally - Indomethacin: First-line for many years; side effects: transient renal impairment, NEC, GI bleeding, platelet dysfunction - Ibuprofen: Similar efficacy, fewer renal side effects, less effect on mesenteric blood flow - Paracetamol (acetaminophen): Emerging as an alternative; mechanism thought to be via peroxidise inhibition at the COX active site (specifically the peroxidase domain of the prostaglandin H₂ synthase complex) - Surgical ligation: Reserved for haemodynamically significant PDA refractory to medical therapy

Clinical Question: Why does indomethacin close PDA? → It inhibits COX, reducing PGE₂, thereby removing the main vasodilator maintaining ductal patency.

Clinical Question: Why does the ductus remain patent in utero? → High PGE₂ from placenta and ductus wall + low O₂ tension prevent constriction.

2.6 Summary of Shunt Closure Timelines

3. Placental Physiology

3.1 Structure of the Placenta

The mature placenta at term is:

• Weight: ~450–500 g (fetal:placental weight ratio ~6:1 at term)
• Diameter: ~20 cm
• Thickness: ~2.0–2.5 cm
• Surface area of villous interface: ~10–12 m² (equivalent to one side of a tennis court)
• Blood flow:
• Uteroplacental (maternal side): ~600–800 mL/min at term (~80% to intervillous space)
• Fetoplacental (fetal side): ~400–500 mL/min at term

Basic structure: The functional unit is the chorionic villus. Each villus contains fetal capillaries (derived from the umbilical circulation) bathed directly in maternal blood within the intervillous space.

3.2 Placental Transport Mechanisms

The placenta is not a passive filter but a highly selective organ with multiple transport mechanisms.

3.2.1 Simple Diffusion

Characteristics: Passive movement down concentration gradient. No energy requirement. No carrier. Rate determined by Fick's law:

Rate of diffusion ∝ (Surface area × Concentration gradient × Solubility) / (Membrane thickness)

3.2.2 Facilitated Diffusion

Characteristics: Carrier-mediated, saturable, stereospecific. Down concentration gradient (no energy against gradient). Requires specific transporter proteins.

Clinical Note: In maternal diabetes, sustained maternal hyperglycaemia saturates GLUT1 transporters and leads to fetal hyperglycaemia → fetal hyperinsulinaemia → accelerated growth (macrosomia). Tight glycaemic control is essential.

3.2.3 Active Transport

Characteristics: Carrier-mediated, energy-dependent (ATP, ion gradients), can move AGAINST concentration gradients. Saturable, selective.

Placental Amino Acid Transport and IUGR: In IUGR, activity of System A (Na⁺-dependent neutral amino acid transport) is significantly reduced in the microvillous membrane. This is disease-specific — placental insufficiency reduces transporter activity even before fetal growth restriction is clinically apparent. System A activity measurement from placental biopsies may become a biomarker.

3.2.4 Pinocytosis / Endocytosis

Characteristics: Engulfment of extracellular fluid/macromolecules into vesicles. Used primarily for large molecules.

Clinical Correlation: Premature infants (<32 weeks) have low IgG levels because they miss the majority of placental IgG transfer. This contributes to their immunocompromised state.

3.2.5 Bulk Flow / Solvent Drag

Characteristics: Movement of water and dissolved solutes through large pores or channels driven by hydrostatic or osmotic pressure gradients.

• Water: Moves via aquaporins (AQP1, 3, 8, 9 expressed in placental trophoblast and fetal membranes) and across lipid bilayer.
• Small solutes: Follow water if molecular size allows passage through paracellular channels (pores ~10–15 nm in syncytiotrophoblast).

3.3 Placental Metabolism

The placenta is metabolically highly active, consuming ~40% of the oxygen transferred from mother to fetus.

3.4 Placental Hormone Production

The placenta is an endocrine organ, secreting a wide range of hormones and growth factors that regulate maternal adaptations to pregnancy and fetal development.

3.4.1 Human Chorionic Gonadotropin (hCG)

3.4.2 Human Placental Lactogen (hPL)

Clinical Note: hPL levels are low in IUGR (reflects small placental mass) and high in multiple pregnancy and diabetes.

3.4.3 Progesterone

Progesterone Withdrawal and Labour: In most mammals, a fall in progesterone triggers parturition. In humans, there is no systemic progesterone withdrawal; instead, there is a functional progesterone withdrawal mediated by changes in progesterone receptor isoforms (PR-A increases relative to PR-B in myometrium) and local metabolism of progesterone.

3.4.4 Oestrogen

Clinical Correlation: Low/unconjugated oestriol (uE3) is part of second-trimester screening for Down syndrome (low uE3). Extremely low oestriol levels occur in placental sulphatase deficiency (X-linked ichthyosis) — male fetus, low oestrogen, prolonged pregnancy, failure of cervical ripening.

3.4.5 Placental Growth Hormone (GH-V)

3.4.6 Relaxin

3.4.7 Corticotropin-Releasing Hormone (CRH)

3.5 Placental Drug Transfer

The placenta is not an absolute barrier. Most drugs and substances in the maternal circulation will cross to some extent. Key determinants:

3.5.1 Ion Trapping

Weak bases accumulate in the fetal compartment because fetal pH is slightly more acidic (pH ~7.25–7.30) than maternal pH (~7.40). Basic drugs are ionised (trapped) in the acidic environment, limiting transfer back to mother.

• Weak bases (e.g., pethidine, bupivacaine, diazepam): Unionised form crosses placenta; once in fetal circulation with slightly lower pH, the drug becomes ionised and "trapped."
• Weak acids (e.g., phenobarbital, phenytoin): Less trapping in fetal compartment; more likely to equilibrate.

3.5.2 P-glycoprotein (P-gp)

• Location: Syncytiotrophoblast (maternal-facing microvillous membrane).
• Function: ATP-dependent efflux pump. Transports drugs OUT of the trophoblast back into maternal blood — essentially a "guardian" protecting the fetus.
• Substrates: Digoxin, vincristine, dexamethasone, tacrolimus, saquinavir.
• Regulation: Expression increases with gestational age. Polymorphisms may affect fetal drug exposure.

3.5.3 Clinically Important Drug Transfers

4. Fetal Endocrinology

4.1 Fetal Hypothalamic–Pituitary Axis

The fetal hypothalamic-pituitary system matures progressively during gestation.

Key concept: The fetal HPA axis is functional from ~20 weeks but is suppressed by high circulating corticosteroids (cortisol, oestrogen) which inhibit CRH and ACTH via negative feedback. This suppression is gradually lost near term (the "cortisol surge").

4.2 Fetal Thyroid

4.2.1 Development

4.2.2 Physiology

Key Points: - Maternal T₄ crosses the placenta in small amounts (~10–15% of fetal T₄ requirement). For fetal brain development, early T₄ supply is critical (before fetal thyroid is functional). - Iodine: Essential for T₄ synthesis. Fetal thyroid actively concentrates iodine via the Na⁺/I⁻ symporter (NIS) from ~12 weeks. Iodine deficiency → fetal hypothyroidism → cretinism (neurodevelopmental impairment). - Congenital hypothyroidism: Most cases are due to thyroid dysgenesis. Newborn screening (Guthrie test — heel prick at 5–8 days) checks TSH. Early treatment prevents neurodevelopmental delay.

4.2.3 Role of Iodine

• The fetal thyroid requires ~50–75 μg iodine/day by late gestation.
• Maternal iodine deficiency causes:
• Fetal goitre
• Congenital hypothyroidism → cretinism (irreversible brain damage)
• Increased miscarriage, stillbirth
• WHO recommends 250 μg iodine/day in pregnancy.
• Excess iodine also harmful: Wolff-Chaikoff effect (fetal thyroid is very sensitive — maternal ingestion of excess iodine suppresses fetal T₄ → goitre, hypothyroidism).

4.3 Fetal Adrenal Gland

4.3.1 Structure

The fetal adrenal is disproportionately large compared to the adult: at term, each fetal adrenal weighs ~4 g (the same as in an adult, but the adult weighs 4–5 g each and the fetus is 20× smaller). The gland is composed of two zones:

4.3.2 Steroidogenic Pathways

The fetal adrenal is deficient in 3β-hydroxysteroid dehydrogenase (3β-HSD) in the fetal zone. This means:

• Δ⁵ pathway (pregnenolone → 17-OH pregnenolone → DHEA → DHEA-S) is dominant → massive DHEA-S production
• Δ⁴ pathway (progesterone → 17-OH progesterone → androstenedione) is minimal in fetal zone

DHEA-S production: - Begins ~8–10 weeks - Rises progressively: from ~2 mg/day at 20 weeks to ~200 mg/day at term - 90% of fetal DHEA-S is derived from the fetal zone - DHEA-S → 16α-hydroxy-DHEA-S in fetal liver → precursor for oestriol synthesis in placenta

Feto-Placental Unit Concept:

Fetal adrenal → DHEA-S         → Placenta → Oestrone (E1)
Fetal adrenal → DHEA-S         → Placenta → Oestradiol (E2)
Fetal adrenal → DHEA-S → Fetal liver (16α-hydroxylation) → 16-OH DHEA-S → Placenta → Oestriol (E3)

Clinical Correlation — Congenital Adrenal Hyperplasia (CAH): - 21-hydroxylase deficiency (~90% of CAH) → ↓cortisol, ↑ACTH → ↑adrenal androgen production - Female fetus → virilisation of external genitalia (clitoromegaly, labial fusion) - Male fetus → normal genitalia (testosterone from testes, not adrenals) - Diagnosis: elevated 17-OH progesterone on newborn screening - Prenatal treatment: maternal dexamethasone (suppresses fetal ACTH → ↓androgen production) — controversial due to long-term effects

4.3.3 Adrenarche

The fetal zone undergoes rapid involution after birth — the adrenal shrinks from ~4 g at birth to ~1 g by 3 months. This is due to withdrawal of placental oestrogen and CRH stimulation. The definitive zone (renin-angiotensin regulated) persists.

4.4 Fetal Pancreas

Clinical Correlation — Infant of Diabetic Mother (IDM):

Maternal hyperglycaemia → increased glucose transfer across placenta → fetal hyperglycaemia → fetal β-cell hyperplasia → fetal hyperinsulinaemia → accelerated growth (macrosomia — especially increased truncal fat and organomegaly).

Problems after birth (when cord clamped): 1. Neonatal hypoglycaemia: Abrupt cessation of maternal glucose supply + persistent hyperinsulinaemia → rapid fall in blood glucose (within 1–3 hours). This is the most common and most important complication. 2. Respiratory distress syndrome (RDS): Insulin inhibits surfactant production (antagonises cortisol-mediated maturation) → ↑RDS risk even at term. 3. Polycythaemia: Fetal hyperinsulinaemia → increased erythropoietin → increased RBC mass → hyperviscosity. 4. Hypocalcaemia, hypomagnesaemia: Delayed parathyroid hormone response. 5. Neonatal jaundice: Polycythaemia + hepatic immaturity. 6. Congenital anomalies: Particularly cardiac (VSD, TGA), neural tube defects, caudal regression syndrome (rare but specific to IDM).

4.5 Fetal Lung Maturation

4.5.1 Lung Development Stages

4.5.2 Surfactant System

Definition: Surfactant is a complex mixture of lipids (~90%) and proteins (~10%) that reduces surface tension at the air–liquid interface within alveoli, preventing alveolar collapse at end-expiration.

Composition:

Surfactant Proteins (SP):

Synthesis: - Surfactant is synthesised in type II pneumocytes (also called granular pneumocytes). - Stored in lamellar bodies (dense, onion-like organelles). - Secreted by exocytosis into the alveolar lining fluid. - Unfolds to form tubular myelin (a lattice structure that acts as the reservoir of surfactant). - Adsorbed as a monolayer film at the air–liquid interface.

Regulation: - Stimulators: Cortisol (most important), thyroid hormones (T₃), prolactin, oestrogen, catecholamines (β-agonists), cyclic AMP, androgens (suppress). - Inhibitors: Insulin (important — explains ↑RDS in IDM), androgens (males have delayed maturation → slightly higher RDS risk).

Androgen effect: Male fetuses have delayed surfactant maturation compared to females. This is due to androgen (testosterone) suppressing SP-A and SP-B expression. This is why RDS is slightly more common and severe in male preterm infants.

4.5.3 Surfactant Maturity Tests

These tests assess whether fetal lungs are mature enough to avoid RDS.

Clinical Use: - L:S ratio >2.0: RDS risk <2% - L:S ratio 1.5–2.0: RDS risk ~20–40% - L:S ratio <1.5: RDS risk ~70–80%

Maternal Corticosteroids for Lung Maturation: - Betamethasone (12 mg × 2 doses, 24 hours apart) or Dexamethasone (6 mg × 4 doses, 12 hours apart) - Crosses placenta → induces SP-A, SP-B, SP-C expression + ↑enzyme activity for PC synthesis - Effects seen within 24 hours, maximal at 48 hours–7 days - Reduces RDS risk by ~40–50%, IVH by ~45%, NEC by ~50% - Repeat courses: Controversial; may be considered if risk of preterm delivery persists (but concerns about reduced fetal growth and long-term neurodevelopment)

4.5.4 Cortisol Surge in Late Gestation

The cortisol surge (also called the "pre-partum cortisol surge") is a critical maturational event:

• Fetal cortisol rises from ~20 ng/mL at 30 weeks to ~200 ng/mL at term
• Source: Fetal adrenal (definitive/transitional zone) — stimulated by ACTH from fetal pituitary, which itself is stimulated by placental CRH
• Functions of the cortisol surge:
• Lung maturation: Induction of surfactant synthesis (SP-A, SP-B, PC)
• Enzyme induction: Glucagon, hepatic gluconeogenic enzymes (PEPCK, glucose-6-phosphatase) — prepares for independent glucose regulation
• Gut maturation: ↑Lactase, ↑digestive enzymes
• Thyroid axis: ↑T₄ → T₃ conversion (via ↑D1 deiodinase activity in liver/kidney)
• Immune system: ↑Neutrophil maturation
• Parturition: Stimulates placental prostaglandin production
• β-adrenergic receptors: ↑Expression in myocardium, lungs

5. Fetal Monitoring

5.1 Cardiotocography (CTG) Principles

Cardiotocography is the simultaneous recording of fetal heart rate (FHR) and uterine contractions. Interpretation requires systematic assessment of:

5.1.1 Baseline FHR

5.1.2 Baseline Variability

Variability reflects the interaction between the sympathetic and parasympathetic nervous systems (the "autonomic tug-of-war") on the sinoatrial node.

Clinical Correlation: Loss of variability is a late sign of fetal hypoxia. By the time variability is absent, fetal acidosis is usually severe (pH <7.10). However, variability alone should not be the sole criterion for intervention.

5.1.3 Accelerations

5.1.4 Decelerations

Decelerations are classified by their shape, timing in relation to contractions, and underlying pathophysiology.

5.1.4.1 Early Decelerations

Contour: Gradual (mirrors contraction)
Timing: Nadir coincides with peak of contraction
Onset/offset: Gradual

5.1.4.2 Late Decelerations

Contour: Gradual
Timing: Nadir AFTER peak of contraction (delayed)
Onset/offset: Gradual (after contraction begins/ends)

5.1.4.3 Variable Decelerations

Contour: Variable (V-shaped, abrupt onset, sometimes "overshoot" or "shoulders")
Timing: Variable in relation to contractions

5.1.4.4 Prolonged Deceleration

5.1.5 CTG Classification (NICE 2022 / FIGO 2015)

Overall CTG Classification: - Normal: All features reassuring — no action required beyond routine care. - Suspicious (NICE: non-reassuring): One non-reassuring feature — conservative measures, continue CTG. - Pathological (NICE: abnormal): Any abnormal feature OR two or more non-reassuring features — escalate, consider fetal blood sampling or delivery.

5.2 Fetal Scalp Blood Sampling (FBS)

5.2.1 Indications

• Suspicious/pathological CTG to assess fetal acid-base status
• Exclude metabolic acidosis when CTG is uncertain

5.2.2 Contraindications

• Maternal infection (HIV, hepatitis, HSV)
• Fetal bleeding disorder (haemophilia, von Willebrand)
• Preterm (<34 weeks — risk of haemorrhage)
• Face/brow presentation

5.2.3 Interpretation

Important Limitations: - Not always possible (cervix <3 cm, intact membranes) - Sample may be inadequate (contamination with air → falsely high pH) - Result takes time — may not reflect acute deterioration - Lactate measurement is increasingly used: lactate >4.8 mmol/L → abnormal (delivery indicated)

5.3 Fetal Doppler (Discussed in detail under 1.6)

Quick Summary Table

6. Transition at Birth

Transition from intrauterine to extrauterine life involves the most profound physiological changes in human existence — all occurring within minutes to hours. The key events are:

1. Cord clamping — removal of the low-resistance placental circuit
2. Lung aeration — first breaths establish gas exchange
3. Closure of shunts — foramen ovale, ductus arteriosus, ductus venosus
4. Changes in circulation — from parallel to series

6.1 Cord Clamping

Mechanism of placental transfusion: The low-resistance placental circuit means that after delivery, the baby is essentially "above" the placenta. Gravity and uterine contractions push blood from placenta → baby via the still-pulsating cord. This transfusion is complete within ~3 minutes in vaginally delivered infants.

6.2 Lung Aeration and Establishment of Breathing

6.2.1 The First Breath

The first breath must overcome several physical forces:

The First Breath Sequence:

1. Inspiration: The newborn generates a transpulmonary pressure of ~20–30 cmH₂O (negative intrathoracic pressure) to overcome lung fluid viscosity and surface tension. This may be 2–4× the pressure required for subsequent breaths.
2. Fluid clearance: Lung fluid is pushed from alveoli into the interstitium (driven by the large negative pressure) → absorbed by pulmonary lymphatics and capillaries. ~30–50 mL of lung fluid is cleared in the first 1–2 hours.
3. Functional residual capacity (FRC): After the first breath, ~20–30% of the FRC is established (some alveoli remain fluid-filled initially). Over 2–4 hours, FRC progressively increases.
4. Crying: After the first expiration (which may only allow ~20–30% of air to escape because the glottis closes mid-expiration — the "grunting" mechanism), the baby establishes a crying pattern that further expands the lungs.

Termination of fetal breathing movements: In utero, the fetus makes episodic breathing movements (paradoxical/irregular). These stop during labour (due to prostaglandin E₂, adenosine, and possibly endorphins) and resume immediately after birth.

6.2.2 Surfactant Function After Birth

• Surfactant synthesis accelerates in the first hours/days after birth
• The surface tension at the air–liquid interface is reduced from ~30 dynes/cm to <5 dynes/cm at end-expiration
• This prevents alveolar collapse (atelectasis) and reduces work of breathing
• Deficiency → Neonatal RDS (hyaline membrane disease)

6.2.3 Changes in Pulmonary Vascular Resistance (PVR)

Mechanisms of PVR fall: 1. O₂ vasodilation: The acute rise in alveolar pO₂ (from ~0 to >100 mmHg) is the most potent pulmonary vasodilator 2. Mechanical expansion: Physical expansion of the lungs stretches pulmonary vessels → ↓resistance 3. NO production: ↑Shear stress from increased pulmonary blood flow → endothelial NO synthase activation → NO-mediated vasodilation 4. Prostacyclin (PGI₂): Released from pulmonary endothelium

Clinical Correlation — Persistent Pulmonary Hypertension of the Newborn (PPHN): If PVR fails to fall appropriately after birth (due to meconium aspiration, severe asphyxia, congenital diaphragmatic hernia, or idiopathic), the right-to-left shunt through the ductus arteriosus and foramen ovale persists → severe hypoxaemia. Treatment: inhaled nitric oxide (iNO) — a selective pulmonary vasodilator.

6.3 Changes in Systemic Vascular Resistance (SVR)

Net effect on circulation:

Before birth: - SVR ~50 mmHg mean pressure (low, due to placenta) - PVR ~50–60 mmHg (high) - Blood bypasses lungs via shunts

After birth: - SVR ~70–80 mmHg (higher) - PVR ~15–20 mmHg (low) - Blood flows through lungs (pulmonary circulation established)

6.4 Changes in Cardiac Output and Ventricular Function

6.5 Closure of Shunts (Detailed Already Under Section 2.5)

Summary of Shunt Closure at Birth:

Why is the ductus arteriosus the last to close? Because it has a muscular wall that requires O₂-induced vasoconstriction and PGE₂ clearance for closure. Preterm infants have immature O₂ sensing → may take days to weeks to close.

6.6 Transition of the Fetal Heart

From parallel to series circulation:

• Before birth: The two ventricles pump in parallel. RV → pulmonary artery → ductus arteriosus → descending aorta. LV → ascending aorta.
• After birth: The two ventricles pump in series. RV → pulmonary artery → lungs → pulmonary veins → LA → LV → aorta. This is the "adult" configuration.

The change is not immediate: For the first 10–15 hours, the ductus arteriosus may still allow a small left-to-right shunt (aorta → pulmonary artery). This is normal. Eventually, ductal closure creates the ligamentum arteriosum.

7. Neonatal Physiology

7.1 Thermoregulation

The newborn infant faces a significant thermoregulatory challenge: leaving the warm intrauterine environment (~37.5°C) for the relatively cool extrauterine world (typically ~25°C in delivery rooms). The neonate has: - A large surface area:body weight ratio (3× that of adult) → ↑heat loss - Limited insulation (thin subcutaneous fat) - Immature thermoregulatory control (hypothalamus not fully mature) - Limited metabolic reserve

7.1.1 Mechanisms of Heat Loss

7.1.2 Brown Adipose Tissue (BAT) and Non-Shivering Thermogenesis

Brown adipose tissue (BAT) is the primary organ for heat production in the newborn. Unlike white fat, BAT is specialised for thermogenesis.

Mechanism of Non-Shivering Thermogenesis:

1. Cold stimulus → skin thermoreceptors → hypothalamus (preoptic area)
2. Sympathetic activation → release of noradrenaline → β₃-adrenergic receptors on BAT
3. β₃ activation → ↑lipolysis (hormone-sensitive lipase) → free fatty acids released
4. FFAs activate uncoupling protein 1 (UCP1) — the key thermogenic molecule

5. UCP1 (also called thermogenin) is located in the inner mitochondrial membrane. It creates a proton leak across the inner membrane: instead of protons flowing through ATP synthase to make ATP, they flow through UCP1, dissipating the proton gradient as heat.

6. Normal BAT heat production: ~20–30 kcal/kg/day (can increase 2–3× in cold stress)

7. Substrates: Brown fat stores (triglycerides) + glucose (from liver glycogenolysis)
8. Shivering: Rarely seen in term infants — non-shivering thermogenesis is the dominant mechanism. Preterm infants have limited BAT and may begin shivering (inefficient) when cold.

7.1.3 Cold Stress — Consequences

Cold stress (also called "hypothermic stress") is defined as a thermal challenge that activates thermoregulatory mechanisms. It has significant metabolic and clinical consequences:

The warm chain: To prevent cold stress, WHO recommends: 1. Warm delivery room (>25°C) 2. Immediate drying (removes wetness → reduces evaporative heat loss) 3. Skin-to-skin contact (with mother) 4. Warm blankets/incubator 5. Warm resuscitation equipment 6. Avoidance of drafts

7.2 Neonatal Jaundice

7.2.1 Bilirubin Metabolism

Bilirubin Production: - Bilirubin is derived from the catabolism of haem (from haemoglobin, myoglobin, cytochromes, catalase). - The neonate produces bilirubin at a rate of ~6–8 mg/kg/day (vs adult 3–4 mg/kg/day). - This higher rate is due to: 1. Higher haemoglobin concentration (15–17 g/dL at birth) 2. Shorter RBC lifespan (70–90 days vs 120 days in adult) 3. Increased enterohepatic circulation of bilirubin in the newborn

Metabolism Pathway:

Haem → Haem oxygenase → Biliverdin → Biliverdin reductase → **Unconjugated bilirubin (UCB)**
    ↓
UCB is lipid-soluble → cannot be excreted in urine/bile
    ↓
UCB binds to albumin → transported to liver
    ↓
**Liver:** UCB → UDP-glucuronosyltransferase (UGT1A1) → Bilirubin diglucuronide (**conjugated bilirubin**)
    ↓
Conjugated bilirubin is water-soluble → excreted in bile → gut
    ↓
In gut: β-glucuronidase (from gut bacteria or present in meconium) → deconjugation → unconjugated bilirubin reabsorbed (**enterohepatic circulation**)
    ↓
Excreted in stool

7.2.2 Physiological Jaundice

Definition: Transient unconjugated hyperbilirubinaemia appearing after 24 hours of life in an otherwise healthy term infant.

Timing: - Onset: Day 2–3 - Peak: Day 3–5 (term), Day 5–7 (preterm) - Resolution: Day 10–14 (term), day 14–21 (preterm)

Causes: 1. ↑Bilirubin load (↑RBC breakdown, shorter RBC lifespan) 2. ↓Hepatic uptake of bilirubin (ligandin (Y-protein) is low in the newborn — only ~1% of adult levels at birth, rises over first 2 weeks) 3. ↓Conjugation (UGT1A1 activity is only ~0.1–1% of adult levels at birth; increases to ~30% by 2 weeks) 4. ↑Enterohepatic circulation (meconium in gut, low gut motility, β-glucuronidase activity)

Pathological jaundice is suspected if: - Onset <24 hours of age - Total bilirubin >95th centile for hour of age - Direct (conjugated) bilirubin >20 μmol/L (if >20% of total) - Persisting >14 days (term) or >21 days (preterm) - Signs of kernicterus (see below)

7.2.3 Breast Milk Jaundice

Two types:

7.2.4 Kernicterus (Bilirubin Encephalopathy)

Pathophysiology: Unconjugated bilirubin (lipid-soluble) crosses the blood–brain barrier (especially when albumin binding sites are saturated or disrupted) and deposits in the basal ganglia (globus pallidus, subthalamic nuclei), hippocampus, cerebellum, and cranial nerve nuclei.

Risk factors for kernicterus: - Low gestational age (preterm — lower albumin, disrupted BBB) - Very high bilirubin levels (>340 μmol/L at term, lower thresholds for preterm) - Rapid rise (>8.5 μmol/L/hour) - Low albumin (↓binding capacity) - Hypoxia, acidosis, sepsis (displace bilirubin from albumin) - Drugs (sulfonamides, ceftriaxone — displace bilirubin from albumin)

Stages of bilirubin encephalopathy:

NOTE: The term "kernicterus" literally means "yellow nuclei" — describing the yellow staining of the basal ganglia seen at autopsy. It is used interchangeably with chronic bilirubin encephalopathy.

7.2.5 Phototherapy

Mechanism of Action:

Phototherapy uses blue light (wavelength 450–470 nm) to convert unconjugated bilirubin into water-soluble isomers that can be excreted without conjugation:

1. Photoisomerisation (~80%): Bilirubin is converted to lumirubin (a structural isomer) — this is the main therapeutic effect. Lumirubin is more water-soluble and can be excreted in bile and urine.
2. Photo-oxidation (~20%): Bilirubin is oxidised to colourless, water-soluble products (biliverdin, dipyrroles, monopyrroles). This is slower.
3. Configurational isomerisation: Bilirubin converts to 4Z,15E-bilirubin (reversible) — excreted in bile but may revert to native bilirubin in gut.

Types of phototherapy:

Side effects: Dehydration (insensible water loss), loose stools, skin rash, hyperthermia, "bronze baby syndrome" (if direct hyperbilirubinaemia).

7.2.6 Exchange Transfusion

Indications: - Bilirubin levels above exchange transfusion thresholds (gestation-dependent and risk-factor adjusted) - Rapid rise in bilirubin (>8.5 μmol/L/hour) despite intensive phototherapy - Signs of acute bilirubin encephalopathy (regardless of level)

Procedure: - Double-volume exchange transfusion (160–180 mL/kg) — 2 blood volumes removed and replaced - Done in aliquots (5–10 mL/kg), alternating withdrawal and infusion - Removes ~85% of circulating bilirubin + sensitised RBCs + anti-Rh antibodies

Risks: Hypocalcaemia (citrate in donor blood), hypoglycaemia (high glucose in donor blood), infection (CMV, hepatitis, HIV — reduced by screening), NEC, thrombosis, arrhythmias, portal hypertension (catheter-related).

7.3 Neonatal Respiratory Function

7.3.1 Surfactant Deficiency and RDS

Respiratory Distress Syndrome (RDS) — also called hyaline membrane disease — is caused by primary surfactant deficiency in preterm infants.

Pathophysiology: 1. Surfactant deficiency → high surface tension at air–liquid interface 2. Alveolar collapse at end-expiration (atelectasis) — diffuse microatelectasis 3. ↓Functional residual capacity → ↓lung compliance 4. Ventilation–perfusion mismatch (V̇/Q̇ mismatch) → hypoxaemia 5. Increased work of breathing → respiratory acidosis 6. Proteinaceous exudate (fibrin) leaks into alveoli → forms hyaline membranes (eosinophilic, lining terminal airways) 7. Epithelial necrosis, inflammation → further surfactant inactivation

Risk factors: - Prematurity (the primary risk factor — RDS risk is inversely proportional to gestational age) - Male sex (androgen delays surfactant maturation) - Maternal diabetes (insulin inhibits surfactant) - Multiple pregnancy (preterm delivery) - Caesarean section without labour (labour-related cortisol surge may accelerate maturation) - Perinatal asphyxia (acidosis inhibits surfactant production) - Family history of RDS

Protective factors: - Maternal corticosteroids (betamethasone/dexamethasone) - Female sex (oestrogen accelerates surfactant production) - Pregnancy-induced hypertension / pre-eclampsia (chronic stress → ↑fetal cortisol → accelerated maturation) - Prolonged rupture of membranes (stress → cortisol surge) - Intrauterine growth restriction (chronic stress → ↑cortisol)

Clinical features (within first 6 hours): - Tachypnoea (>60 breaths/min) - Grunting (expiratory — auto-PEEP to splint airways open) - Intercostal/subcostal retractions - Nasal flaring - Cyanosis (in room air) - CXR: Ground-glass appearance (diffuse microatelectasis) with air bronchograms (air-filled bronchi visible against collapsed alveoli)

Prevention: - Antenatal corticosteroids (betamethasone/dexamethasone) - Prophylactic surfactant (in high-risk preterm infants <28 weeks, given in delivery room) - Delayed cord clamping (↑transfusion → ↑haemoglobin → ↑O₂-carrying capacity)

Treatment: - Exogenous surfactant (poractant alfa, beractant, calfactant) — given endotracheally. Reduces mortality by ~40%. - CPAP (continuous positive airway pressure) — maintains FRC, prevents atelectasis. - Mechanical ventilation — rescue surfactant + volume-targeted ventilation. - Supportive care: Temperature control, fluid management, glucose homeostasis.

7.3.2 Periodic Breathing and Apnoea of Prematurity

Periodic Breathing: - Definition: Cessation of breathing for <20 seconds, OR <20 seconds with cyanosis/bradycardia. - Pattern: 5–15 seconds of apnoea followed by rapid breathing (fast breathing for 10–20 seconds). - Common in preterm infants (especially <34 weeks). Incidence ~50% in infants <1500g. - Benign — does not require treatment if self-limiting, no desaturation or bradycardia. - Associated with: Immature respiratory control centre, immaturity of peripheral chemoreceptors.

Apnoea of Prematurity (AOP):

7.4 Glucose Homeostasis

7.4.1 Normal Transition

In utero, the fetus receives a continuous supply of glucose from the mother across the placenta (concentration ~5 mmol/L maternal → ~3.5–4.5 mmol/L fetal). After birth, this supply is abruptly cut off (cord clamping), and the newborn must regulate its own blood glucose.

Normal neonatal blood glucose: - Term: 2.6–5.0 mmol/L (WHO definition of neonatal hypoglycaemia: <2.6 mmol/L) - Preterm: Lower thresholds used by some units (<2.2–2.5 mmol/L)

Sources of glucose after birth:

1. Glycogenolysis (immediate): Hepatic glycogen stores (~34 g at term, from 20 weeks accumulation) → glucose. Depleted within 8–12 hours after birth.
2. Gluconeogenesis (within 2–4 hours): From lactate, pyruvate, amino acids (alanine), glycerol. Requires enzymes (PEPCK, glucose-6-phosphatase, fructose-1,6-bisphosphatase) — these are induced by the cortisol surge in late gestation.
3. Fatty acid oxidation: Provides alternative fuel (ketones) for the brain → spares glucose.
4. Feeding: Breast milk/formula provides lactose → glucose.

Hormonal regulation after birth:

7.4.2 Neonatal Hypoglycaemia — Risk Factors and Pathophysiology

Definition: Blood glucose <2.6 mmol/L (WHO, BAPM). Some units use <2.2 mmol/L for the first 4–12 hours in at-risk infants, but <2.6 mmol/L is the threshold associated with neurodevelopmental impairment.

Risk Factors:

Pathophysiology of Hypoglycaemia in IDM (most common clinical scenario): - Maternal hyperglycaemia → fetal hyperglycaemia → fetal β-cell hyperplasia → fetal hyperinsulinaemia - At birth: cord clamping cuts off glucose supply → but insulin is still high (clearance times ~6–12 hours) - Rapid fall in blood glucose within 1–3 hours - High insulin → suppresses gluconeogenesis, glycogenolysis, lipolysis → no alternative fuel sources available → severe hypoglycaemia - Asymptomatic or symptomatic (jitteriness, lethargy, seizures, apnoea, cyanosis, hypothermia)

Treatment: - Asymptomatic: Early feeding (breast/formula), monitor glucose hourly - Symptomatic or severe (<1.0 mmol/L): IV 10% dextrose (2 mL/kg bolus, then continuous infusion) - Refractory: Consider glucagon, diazoxide, octreotide (for hyperinsulinism) - Monitoring: Regularly until stable (>2.6 mmol/L for 3 consecutive feeds)

7.5 Fluid and Electrolyte Balance

7.5.1 Body Water Composition at Birth

• The first week of life: All newborns lose ~5–10% of birth weight (term) or ~10–15% (preterm). This is primarily loss of extracellular water.
• Diuresis occurs on day 2–3 of life — the "physiological diuresis" — followed by a nadir weight and then weight gain.

7.5.2 High Insensible Water Loss in Prematurity

Insensible Water Loss (IWL) estimates:

Management: Use humidified incubators (humidity 60–90% reduces IWL by 50–70%), fluid management tailored to daily weight, serum Na⁺, urine output.

7.5.3 Renal Immaturity in the Newborn

The neonatal kidney is structurally and functionally immature:

Consequences of renal immaturity: 1. Limited ability to concentrate urine → rapid dehydration if water-deprived 2. Limited ability to excrete Na⁺ → risk of hypernatraemia if given high Na⁺ 3. Limited ability to reabsorb Na⁺ (in preterm) → risk of hyponatraemia and salt-wasting 4. Limited acid excretion → tendency to metabolic acidosis 5. Immature renin-angiotensin system → further limitations on Na⁺/K⁺ homeostasis

7.6 Neonatal Immune System

7.6.1 Passive Immunity: Maternal IgG Transfer

Placental IgG Transfer: - IgG is the only antibody class that crosses the placenta in significant amounts. - Mechanism: FcRn (neonatal Fc receptor) on syncytiotrophoblast → receptor-mediated transcytosis from maternal to fetal side. - Timing: Begins ~13–16 weeks; minimal before 20 weeks; accelerates exponentially after 22 weeks; most transfer occurs in the third trimester (≥32 weeks).

Consequences: - Term infants have passive IgG protection against vaccine-preventable diseases (measles, mumps, rubella, tetanus, diphtheria, polio, Hib, pneumococcus) for the first 3–6 months. - Preterm infants have low IgG levels and are at increased risk of serious bacterial infections (GBS, E. coli, Listeria). - Maternal IgG is catabolised over 6–12 months; infant's own IgG synthesis begins around 3–6 months.

7.6.2 IgA in Breast Milk

Other immune factors in breast milk: - Lactoferrin (iron-binding — bacteriostatic) - Lysozyme (breaks down bacterial cell walls) - Oligosaccharides (prebiotic — promote healthy gut microbiome) - Cytokines, macrophages, lymphocytes, neutrophils - Not just IgA: Breast milk also contains IgG, IgM, IgE (in smaller amounts)

7.6.3 Neonatal Cellular Immunity

The neonatal immune system has several immaturities:

Why is the newborn at risk of sepsis?

• Immature innate immunity
• Low IgG (preterm) and IgA
• Limited ability to fight encapsulated bacteria (GBS, E. coli — require opsonisation)
• Skin barrier immature in preterm
• Mucosal barrier immature (gut, respiratory tract)
• Lack of experience-adapted immune responses
• Reduced chemotaxis, phagocytosis, intracellular killing

8. Acid-Base Balance in Labour

8.1 Fetal Acid-Base Physiology

Fetal acid-base status reflects the balance between: - Metabolic production of acids (CO₂, lactic acid) by fetal tissues - Removal of CO₂ and H⁺ via the placenta

Normal fetal blood gas values in labour (scalp or cord blood):

8.2 Cord Blood Gas Analysis

Umbilical cord blood gas analysis is the gold standard for assessing fetal acid-base status at delivery. Both arterial (UA) and venous (UV) samples are taken.

8.2.1 Sampling Method

• Umbilical artery (UA): Reflects fetal metabolic state (blood returning from fetus to placenta)
• Umbilical vein (UV): Reflects placental function (oxygenated blood going to fetus)
• Sampling: Clamp a segment of cord immediately after delivery (before the first breath if possible). Draw from UA (2 smaller, thinner-walled vessels) and UV (1 larger vessel).
• Arterial–venous differences: Normally, UA pH is slightly lower than UV pH, UA pCO₂ higher, UA pO₂ lower, UA BD higher.

8.2.2 Normal Cord Blood Gas Values

Difference (UA–UV): - ΔpH: normally 0.05–0.15 - ΔpCO₂: normally 5–10 mmHg (UA higher) - Difference >0.2 in pH or >20 mmHg in pCO₂ suggests an intermediary obstruction (cord compression)

8.2.3 Interpretation

pH <7.00 + BD ≥12 mmol/L is often used to define significant intrapartum acidosis (associated with increased risk of neonatal encephalopathy).

Risk of neonatal encephalopathy by UA pH:

However, pH alone is not sufficient to predict outcome. Most infants with low cord pH do NOT develop encephalopathy. Additional factors: duration of acidosis, metabolic vs respiratory nature, presence of seizures, Apgar scores.

8.3 Types of Fetal Acidosis

8.3.1 Respiratory Acidosis

Pathophysiology: - Umbilical cord compression → occlusion of umbilical vein and/or artery - CO₂ cannot be cleared via the placenta (CO₂ clearance is flow-dependent) - CO₂ accumulates → acute rise in pCO₂ - H₂O + CO₂ ↔ H₂CO₃ ↔ H⁺ + HCO₃⁻ (carbonic acid equilibrium) - Acute respiratory acidosis → pH falls inversely with pCO₂ rise (ΔpH ~0.08 for each 10 mmHg rise in pCO₂) - No tissue hypoxia (O₂ can still be delivered if UA flow is maintained or partially patent)

Clinical scenario: Variable decelerations, nuchal cord. Rapid changes in pH (can drop from 7.30 to 7.10 within minutes).

Prognosis: Excellent if relieved quickly (e.g., cord repositioned, delivery expedited). The acidosis resolves within minutes of birth once the infant breathes (lungs clear CO₂).

8.3.2 Metabolic Acidosis

Pathophysiology: - Uteroplacental insufficiency → ↓O₂ delivery to fetus - Fetal tissues switch to anaerobic metabolism (↓ATP production per molecule of glucose — 2 ATP vs 38 ATP) - Anaerobic glycolysis → pyruvate → lactic acid + H⁺ - Lactic acid accumulates because it cannot be cleared via the placenta as quickly as it is produced - Base deficit rises (>12 mmol/L represents significant lactic acidosis) - pCO₂ may be normal or even low (if fetus hyperventilates via placental circulation — but this is limited)

Clinical scenario: Pre-eclampsia, placental abruption, post-maturity, prolonged late decelerations.

Prognosis: Worse than respiratory acidosis. Metabolic acidosis indicates tissue hypoxia. The longer the duration and the higher the base deficit, the greater the risk of neonatal encephalopathy and multi-organ dysfunction.

8.3.3 Mixed Acidosis

Pathophysiology: - Combination of cord compression (↑pCO₂) + tissue hypoxia (↑lactate) - Most common pattern in severe intrapartum asphyxia - pH falls rapidly and profoundly due to the combined effect of CO₂ retention and lactic acid accumulation

Clinical scenario: Prolonged cord compression (e.g., cord prolapse) combined with poor placental reserve. Or severe tachysystole (uterine hyperstimulation) reducing both O₂ delivery and CO₂ clearance.

Prognosis: Worst. Highest risk of neonatal encephalopathy, multiorgan failure, cerebral palsy.

8.4 Correlation with Apgar Scores

The Apgar score (Appearance, Pulse, Grimace, Activity, Respiration) is a rapid clinical assessment tool at 1, 5, and 10 minutes after birth.

Interpretation: - 7–10: Normal — no concern - 4–6: Moderately depressed — may need stimulation, O₂, CPAP - 0–3: Severely depressed — likely requiring full resuscitation

Apgar score alone is NOT a measure of intrapartum acidosis — it reflects the infant's condition at a single point in time and is affected by: prematurity, maternal sedation, congenital anomalies, infection, trauma.

Relationship between Apgar and cord pH:

In general: An Apgar score of 0–3 at ≥5 minutes with a cord arterial pH <7.00 and base deficit ≥12 mmol/L is one of the criteria for defining an acute intrapartum hypoxic event (according to the American College of Obstetricians and Gynecologists [ACOG] and the International Cerebral Palsy Task Force).

8.5 Clinical Approach to Cord Blood Gas Interpretation

Step 1: Is there acidosis? (UA pH <7.15) - If no → likely no significant intrapartum hypoxia (reassuring) - If yes → proceed to Step 2

Step 2: What type of acidosis? - Respiratory: ↑pCO₂ (>60), BD normal or <12, lactate low/normal. Likely cord compression. Good prognosis. - Metabolic: Normal pCO₂ or ↓, BD ≥12, lactate ≥6. Likely uteroplacental insufficiency. Worse prognosis. - Mixed: ↑pCO₂ + ↑BD. Severe insult. Very concerning.

Step 3: Is it clinically significant? - pH <7.00 + BD ≥12 → significant metabolic acidosis (risk of encephalopathy) - pH 7.00–7.10 → borderline — correlate with clinical picture - pH >7.10 despite poor CTG → unlikely to have hypoxic-ischaemic encephalopathy (HIE)

Step 4: Consider the AV difference (UA–UV) - ΔpH >0.2 → suggests acute cord compression near delivery - ΔpH 0.05–0.15 → normal - UA–UV difference in pCO₂ >20 mmHg → cord compression - Very small UA–UV difference → could indicate poor placental function or contamination

8.6 Lactate as a Marker of Fetal Acidosis

Lactate measurement in fetal scalp blood and cord blood is increasingly used:

Advantages of lactate over pH: - Requires smaller sample volume (5 μL vs 35 μL for pH) - More rapid result - More specific for metabolic (hypoxic) acidosis — less influenced by CO₂ changes (respiratory component) - Less affected by contamination with air or maternal blood

Disadvantages: - Not a good marker of acute respiratory acidosis - Can be elevated in less severe forms of stress (catecholamine-driven) - Less validated than pH for long-term outcome prediction

9. Summary Tables & Revision Aids

9.1 Fetal Shunts — Rapid Revision Table

9.2 Oxygen Saturations at Key Points

9.3 Placental Transport — Quick Glance

9.4 Neonatal Jaundice — Differential Diagnosis by Timing

9.5 Types of Fetal Acidosis — Summary

9.6 Fetal Growth — Key Numerical Facts

10. Clinical Correlations Compendium

Use this section for quick revision of the most frequently examined clinical scenarios.

10.1 Fetal Physiology

Q: What is the significance of the ductus venosus? A: Shunts ~50–60% of well-oxygenated umbilical venous blood past the liver directly into the IVC, ensuring the most oxygenated blood reaches the fetal brain and heart.

Q: Why is HbF important for the fetus? A: HbF has higher O₂ affinity (P50 ~19–21 mmHg vs 26–28 mmHg for HbA) due to poor 2,3-DPG binding. This allows O₂ loading at the low pO₂ of the placenta (~30–35 mmHg) and is enhanced by the double Bohr effect.

Q: Why does the ductus arteriosus close after birth? A: Increased O₂ tension (first breath → lung aeration → pO₂ from ~20 to >100 mmHg) → inhibits Kv channels → depolarisation → Ca²⁺ influx → smooth muscle constriction. Plus ↓PGE₂ (placental removal + pulmonary clearance).

Q: Why does indomethacin close PDA? A: COX inhibition → ↓PGE₂ synthesis → removes the primary vasodilator maintaining ductal patency.

Q: Why does the ductus remain patent in utero? A: High PGE₂ (from placenta, ductal wall) + low O₂ tension maintain vasodilation.

Q: What causes asymmetrical IUGR? A: Late pregnancy insult (placental insufficiency) → ↓glycogen/fat stores → ↓AC (liver glycogen) but preserved HC ("brain sparing"). Seen with pre-eclampsia, smoking, maternal vascular disease.

Q: What causes symmetrical IUGR? A: Early insult (first/early second trimester) → chromosomal (T13, T18, T21), TORCH infections, teratogens → reduced cell number → all parameters proportionately reduced.

Q: What is the cerebroplacental ratio (CPR)? A: CPR = MCA PI / UA PI. CPR <5th centile indicates brain sparing (fetal hypoxia). More sensitive than either MCA or UA alone.

Q: What is the significance of reversed a-wave in the ductus venosus? A: Indicates severe right heart failure due to profound hypoxia — a preterminal sign. Delivery usually indicated.

10.2 Placental Physiology

Q: Which placental hormone maintains uterine quiescence? A: Progesterone — suppresses gap junction formation, downregulates oxytocin receptors, maintains myometrial relaxation.

Q: Which placental hormone is the "major metabolic hormone of pregnancy"? A: hPL (human placental lactogen) — causes maternal insulin resistance (sparing glucose for the fetus) and lipolysis (maternal energy from fats).

Q: What is the "placental clock"? A: Placental CRH — rises exponentially through pregnancy, stimulates fetal ACTH → cortisol → lung maturation + prostaglandin synthesis. CRH-BP falls near term → ↑free CRH → triggers parturition.

Q: Why does oestriol require a feto-placental unit? A: Oestriol synthesis requires 16α-hydroxylation of DHEA-S in the fetal liver. The placenta lacks 16α-hydroxylase; the fetal liver provides this → feto-placental unit is essential.

Q: How does maternal diabetes affect the fetus? A: Maternal hyperglycaemia → fetal hyperglycaemia → fetal hyperinsulinaemia → accelerated growth (macrosomia), delayed lung maturation (insulin inhibits surfactant), polycythaemia, neonatal hypoglycaemia.

Q: What is the significance of low maternal serum oestriol? A: Low uE3 is a marker for Down syndrome (triple/quadruple test). Extremely low levels suggest placental sulphatase deficiency (X-linked ichthyosis) — associated with prolonged pregnancy, failure of cervical ripening.

10.3 Fetal Monitoring

Q: What causes early decelerations? A: Head compression → vagal activation → reflex bradycardia. Benign, not associated with hypoxia.

Q: What causes late decelerations? A: Uteroplacental insufficiency → ↓O₂ delivery during contraction → fetal hypoxia → chemoreceptor-mediated vagal slowing. Pathological.

Q: What causes variable decelerations? A: Cord compression → baroreceptor/vagal activation. Can be benign (type 1) or concerning (type 2 — atypical features).

Q: What is the difference between respiratory and metabolic acidosis on cord blood gas? A: Respiratory: ↑pCO₂, normal BD (cord compression). Metabolic: ↓HCO₃⁻, ↑↑BD, normal/normalised pCO₂ (tissue hypoxia). Mixed: both abnormal (severe).

Q: At what fetal scalp pH is delivery indicated? A: pH <7.20 (or lactate ≥4.8 mmol/L). Borderline: 7.20–7.25 — repeat in 30 minutes.

Q: What does absent variability on CTG indicate? A: May be fetal sleep (normal, <40 min), maternal drugs (opioids, MgSO₄), prematurity, or fetal acidosis (ominous — immediate delivery indicated if persistent).

10.4 Neonatal Physiology

Q: Why are preterm infants at risk of hypothermia? A: Large SA:body weight ratio, thin skin, limited brown fat (UCP1), limited glycogen stores for thermogenesis, immature hypothalamus.

Q: What is non-shivering thermogenesis? A: Heat production in brown adipose tissue mediated by UCP1 (uncoupling protein 1) — mitochondrial proton leak generates heat instead of ATP. Activated by cold → sympathetic → β₃-adrenergic → lipolysis → UCP1.

Q: What are the consequences of cold stress in a newborn? A: Hypoglycaemia, metabolic acidosis, hypoxia (R→L shunt through PDA), respiratory distress, lethargy, coagulopathy.

Q: Why does physiological jaundice occur? A: ↑Bilirubin load (high RBC mass, short RBC lifespan) + ↓UGT activity (0.1–1% of adult) + ↓hepatic uptake (low ligandin) + ↑enterohepatic circulation.

Q: When does bilirubin encephalopathy (kernicterus) occur? A: Unconjugated bilirubin >340 μmol/L (term), lower thresholds for preterm. Risk factors: prematurity, low albumin, hypoxia, acidosis, sepsis, displacement by drugs.

Q: How does phototherapy work? A: Blue light (450–470 nm) converts unconjugated bilirubin to lumirubin (photoisomerisation) — water-soluble, excreted in bile/urine without conjugation.

Q: Why do infants of diabetic mothers have respiratory distress? A: Insulin inhibits surfactant production (antagonises cortisol-mediated induction). Even at term, IDM have higher risk of RDS.

Q: Why do preterm infants have apnoea? A: Immature brainstem respiratory centre, poor chemoreceptor sensitivity to CO₂, excess GABA/adenosine, pharyngeal hypotonia. Often mixed (central + obstructive).

Q: Why are preterm infants at risk of infection? A: Low maternal IgG (missed third-trimester transfer), limited neutrophil reserves, immature T-cell function, impaired complement activity.

11. MRCOG Part 1 Exam-Style Questions

Question 1

A 32-year-old woman with pre-eclampsia has an emergency caesarean section at 32 weeks for severe FGR with reversed end-diastolic flow in the umbilical artery. The infant is born in good condition but develops respiratory distress within the first hour. Cord blood gas results are: UA pH 7.22, pCO₂ 48 mmHg, pO₂ 18 mmHg, base deficit 6 mmol/L.

Which of the following best explains the respiratory distress? A) Transient tachypnoea of the newborn B) Meconium aspiration syndrome C) Surfactant deficiency due to prematurity D) Congenital diaphragmatic hernia E) Persistent pulmonary hypertension of the newborn

Answer: C. The infant is preterm (32 weeks) with no evidence of significant acidosis (normal cord gases). The most likely cause of early respiratory distress in a preterm infant is surfactant deficiency → RDS. Pre-eclampsia (which causes chronic fetal stress and corticosteroid surge) can accelerate maturation — but at 32 weeks, especially if antenatal steroids were not given, RDS is still very likely.

Question 2

A term infant is born with a nuchal cord. CTG showed recurrent variable decelerations in the second stage. Cord blood analysis: UA pH 7.16, pCO₂ 72 mmHg, base deficit 7 mmol/L, lactate 4.1 mmol/L.

Which type of acidosis is present? A) Respiratory acidosis B) Metabolic acidosis C) Mixed acidosis D) No acidosis E) Combined metabolic alkalosis

Answer: A. Raised pCO₂ (72 mmHg) with normal base deficit (7 mmol/L) and lactate (4.1 mmol/L) indicates a pure respiratory acidosis. Cord compression prevented CO₂ clearance. The pH is only mildly reduced (7.16). This is a reversible, non-hypoxic acidosis — prognosis is good.

Question 3

Which of the following is the primary mechanism by which oxygen is transferred from mother to fetus at the placenta?

A) Active transport via ATP-dependent pumps B) Facilitated diffusion via carrier proteins C) Simple diffusion down a concentration gradient D) Receptor-mediated endocytosis E) Ion trapping

Answer: C. O₂ crosses the placenta by simple diffusion. The driving force is the concentration gradient (maternal pO₂ ~45–50 mmHg in intervillous space, fetal umbilical venous pO₂ ~30–35 mmHg). The process is flow-limited (not diffusion-limited), meaning that placental blood flow is the main factor determining O₂ transfer.

Question 4

Which of the following is CORRECT concerning fetal haemoglobin (HbF)?

A) HbF has a higher P50 than adult haemoglobin (HbA) B) HbF binds 2,3-DPG more strongly than HbA C) HbF is composed of α₂β₂ chains D) HbF has a left-shifted oxygen dissociation curve compared to HbA E) The transition from HbF to HbA is complete by birth

Answer: D. HbF has a left-shifted dissociation curve (higher O₂ affinity, lower P50 ~19–21 mmHg vs 26–28 mmHg for HbA). This is due to weak binding of 2,3-DPG to the γ-chain. Answer A is wrong (lower P50 in HbF). B is wrong (HbF binds 2,3-DPG weakly). C is wrong (α₂γ₂ for HbF). E is wrong (HbF is ~90% at birth; decreases over 6 months).

Question 5

A 28-week preterm infant develops respiratory distress. Which surfactant component is MOST critical for surface tension reduction?

A) Surfactant protein A (SP-A) B) Surfactant protein B (SP-B) C) Phosphatidylinositol (PI) D) Dipalmitoylphosphatidylcholine (DPPC) E) Surfactant protein D (SP-D)

Answer: D. DPPC (saturated phosphatidylcholine) is the primary surface-active phospholipid responsible for reducing surface tension at the air–liquid interface. SP-B is essential for surfactant function (deficiency is fatal), but DPPC is the major active component. SP-A and SP-D are for host defence. PI is a minor component.

Question 6

Which of the following correctly describes the direction and cause of the foramen ovale shunt?

A) Left-to-right — because RA pressure > LA pressure after birth B) Right-to-left — because LA pressure > RA pressure in utero C) Right-to-left — because RA pressure > LA pressure in utero D) Left-to-right — because LA pressure > RA pressure in utero E) Bidirectional — equal pressures in both atria throughout fetal life

Answer: C. Right-to-left shunt in utero because the collapsed lungs create high PVR → high RV afterload → RA pressure > LA pressure. Blood entering the RA from the IVC is directed toward the FO by the crista dividens and Eustachian valve.

Question 7

A term infant is jaundiced at 5 hours of age. Total bilirubin is 200 μmol/L. Which is the MOST likely cause?

A) Physiological jaundice B) Breast milk jaundice C) Rh haemolytic disease D) Crigler-Najjar syndrome E) Biliary atresia

Answer: C. Jaundice appearing <24 hours of age is ALWAYS pathological and most commonly due to haemolytic disease (Rh or ABO incompatibility). Physiological jaundice appears after 24 hours. Breast milk jaundice is late-onset (day 5–14). Crigler-Najjar is a rare genetic UGT deficiency. Biliary atresia gives conjugated hyperbilirubinaemia presenting later.

Question 8

Which of the following statements about placental drug transfer is TRUE?

A) Heparin crosses the placenta freely due to low molecular weight B) Insulin crosses the placenta and causes fetal hyperinsulinaemia in diabetic mothers C) Weak bases (e.g., pethidine) are more likely to be trapped in the fetal circulation D) P-glycoprotein in the placenta pumps drugs from the fetal to the maternal circulation E) Unionised drugs are less able to cross the placenta

Answer: C. Weak bases become ionised (trapped) in the more acidic fetal compartment (pH ~7.28). A: Heparin is large, highly charged → does NOT cross. B: Insulin crosses poorly (~1%). D: P-gp pumps drugs out of trophoblast back into maternal blood (i.e., protects fetus). E: Unionised drugs cross MORE easily (lipid-soluble).

Question 9

The "double Bohr effect" at the placenta refers to:

A) The simultaneous shift of both maternal and fetal oxygen dissociation curves to enhance O₂ transfer B) The effect of 2,3-DPG on HbF and HbA C) The effect of temperature on fetal oxygen affinity D) The binding of CO₂ to carbamino groups on haemoglobin E) The effect of pH on progesterone binding to its receptor

Answer: A. The double Bohr effect: at the placenta, maternal blood gives up O₂ → pH rises → curve left-shifts → further O₂ release; fetal blood takes up O₂ → pH falls slightly → curve right-shifts → facilitates O₂ unloading later in fetal tissues. Mutually beneficial.

Question 10

Which of the following is NOT a function of brown adipose tissue in the newborn?

A) Non-shivering thermogenesis B) Heat production via UCP1 C) Insulation against cold D) Utilisation of glucose and free fatty acids as fuel E) Mediation of the metabolic response to cold stress

Answer: C. Insulation against cold is a function of white adipose tissue (subcutaneous fat). BAT is specialised for heat production (thermogenesis), not insulation. BAT is highly vascularised and metabolically active — it generates heat, not insulation.

References & Further Reading

1. RCOG Green-top Guideline No. 31: The Investigation and Management of the Small-for-Gestational-Age Fetus (2013, updated 2023).
2. TRUFFLE Study — Timing of delivery in early-onset FGR (Lees et al., 2015, Lancet).
3. NICE Guideline: Intrapartum Care (NG235, 2022) — CTG classification.
4. NICE Guideline: Jaundice in Newborn Babies (CG98, 2010, updated 2016).
5. FIGO Intrapartum Fetal Monitoring Guidelines (2015).
6. GRIT Study — Growth Restriction Intervention Trial.
7. Gardosi J et al. Customised growth charts vs population charts for stillbirth prevention. Lancet 2018.
8. Blackburn ST. Maternal, Fetal, & Neonatal Physiology: A Clinical Perspective. 5th ed. Elsevier.
9. Cunningham FG et al. Williams Obstetrics. 26th ed. McGraw Hill.
10. Moore KL et al. The Developing Human: Clinically Oriented Embryology. 11th ed. Elsevier.
11. Polin RA, Fox WW. Fetal and Neonatal Physiology. 5th ed. Elsevier.
12. Gomella TL. Neonatology: Management, Procedures, On-Call Problems, Diseases, and Drugs. 8th ed. McGraw Hill.

Document prepared for MRCOG Part 1 revision. All clinical correlations are exam-oriented and reflect current UK practice guidelines.

End of Document